melanoma

Why is melanoma resistant to treatment? Findings suggest possible strategy for improvement

Malignant melanoma

Melanoma cells manage to stay alive during treatment with BRAF/MEK inhibitors by shifting how they produce energy, researchers have discovered. Identifying the mechanism behind melanoma resistance to treatment suggests possible strategy for improvement. A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through [...]

Melanoma is able to fend off the body’s immune system

Melanoma, a deadly form of skin cancer, is able to fend off the body's immune system

British researchers have found that melanoma, a deadly form of skin cancer, is able to fend off the body’s immune system. Analysis of tumor and blood samples shows that melanoma knocks out the body’s best immune defence. A potential test could work out which patients are likely to respond to treatment, the Journal of Clinical [...]

Fasting may help to combat cancer and boost chemotherapy effectiveness

Scientists from the University of Southern California say fasting for short periods may help to combat cancer and boost the effectiveness of treatments. Their study found fasting slowed the growth and spread of tumors and cured some cancers when it was combined with chemotherapy. It is hoped that the discovery will prompt the development of [...]

Chemosat was used to treat the first liver cancer patients

Chemosat and metastatic liver cancer

Hepatic Chemosat Delivery System was used to treat the first patients at the European Institute of Oncology (Instituto Europeo di Oncologia – IEO), Milan, Italy, announced Delcath System. Two patients with inoperable liver-dominant metastases from ocular melanoma and gastric cancer were treated with the Generation One version of Chemosat system, and there were no procedure-related [...]

Erivedge for basal cell carcinoma was approved by FDA

Erivedge (vesmodegib) was approved by FDA to treat metastatic basal cell carcinoma.

On January 30, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most frequent type of skin cancer. Genentech (division of Roche) developed the drug in collaboration with Curis. Erivedge will available in pharmacies within one or two weeks. The capsules have to be [...]

Potential way to prevent death from metastatic melanoma: Photoacoustics identifies cancer cells when they spread into the blood stream

Detecting melanoma cells when they start to spread into the blood stream, might be a way to improve treatment and prevention.

A team of researchers from University of Missouri Columbia has developed a method to detect melanoma cells when they start to spread into the blood stream and before they develop into tumors. It is extremely important to identify the cell into the blood stream before they start to grow into a tumor. This may make [...]

Taking multi-vitamin pills is a waste of money as they do nothing for health, a new study found

A team of French researchers spent more than 6 years following 8,000 people and found that those taking supplements were just as likely to have developed cancer or heart disease as those who took an identical-looking dummy pill

The multi-vitamin pills are taken daily by millions of people in the world, hoping to ward off ill-health. However, a major study showed that the vitamin pills do nothing for our health. A team of French researchers spent more than 6 years following 8,000 people and found that those taking supplements were just as likely [...]

Osteoporosis and a daily glass of wine

Osteoporosis occurs when bone mineral density is lower. The bones are fragile and break (fracture) easily.

A study published in the American Journal of Clinical Nutrition showed that moderate consumption of wine can increase bone mineral density (BMD) and prevent post-menopausal fractures linked to osteoporosis.   Researchers from the University of East Anglia and Kings College London have studied over 1,000 pairs of female of age about 55. The subjects were [...]

Melanoma prevention: tanning beds forbidden to minors

Using a tanning device before the age of 20 increases the risk of melanoma by two times.

Taking a new step on preventing melanoma, Edmund G. Brown, Jr., California Governor, signed on October 9 SB 746 into a law that restricts persons under age of 18 from using indoor tanning devices.   The law takes effect starting January 1, 2012. It is the first time in the U.S. when a state interdicts [...]

Abraxane for advanced pancreatic cancer

Abraxane, approved by FDA for breast cancer, could be a life-prolonging drug for patients with advanced pancreatic cancer.

Abraxane plus gemcitabine achieved a median overall survival of 12.2 months in patients with advanced pancreatic cancer, study reports. Patients with high-SPARC biomarker achieved significantly higher overall survival.   Celgene International Sàrl announced on October 6 that results from a clinical study of Abraxane (paclitaxel albumin-bound particles for injectable suspension) in combination with gemcitabine in [...]

Terminal cancer therapy with life-prolonging drugs: “I would hardly call this type of treatment futile.”

Much of terminal cancer therapy is "futile and potentially inconsistent with patients’ wishes", cancer experts say in Lancet Oncology.

Campaigners disagreed with the report concerning terminal cancer patient treatment strategy, especially the exclusion of the drugs that were expected to prolong life for terminal cancer patient.   A report on managing cancer costs, made by 37 cancer experts from developed countries, was published in the Lancet Oncology on September 26 . The study highlights [...]

Ordering Zelboraf

Ordering Zelboraf

Zelboraf (vemurafenib) Tablets – Ordering   Find out more about ordering Zelboraf   Roche’s new drug Zelboraf (also known as PLX4032 and vemurafenib) was approved by the FDA on August 17th 2011 for treatment of melanoma patients whose tumors have BRAF mutations (new Zelboraf announcement order). Now that the drug has been approved, your doctor [...]

Adcetris: the new treatment for Hodgkin lymphoma patients.

Adcetris will be available to patients this week

AstraZeneca received the EU approval for AXANUM   Zelboraf for metastatic melanoma approved by FDA   Seattle Genetics, Inc. (Nasdaq: SGEN) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Adcetris (brentuximab vedotin) for two indications.   1. the treatment of patients with Hodgkin lymphoma after failure of autologous stem [...]

Hereditary cancer: future methods of diagnosis and treatment

Hereditary cancer study

Zelboraf for metastatic melanoma approved by FDA   Prostate cancer: a new treatment option from Swedish Lund University researchers.   Potential breakthrough in cancer research: a new treatment for leukemia had amazing results.   Telomere progressive shortening characterizes familial breast cancer     Medical scientists have found a new form of mechanism leading to hereditary [...]

Zelboraf for metastatic melanoma approved by FDA

Zelboraf may help metastatic melanoma patient to live longer

  Ordering Zelboraf   On Wednesday, August 17, the Food and Drug Administration approved Zelboraf, a drug for BRAF V600E mutation-positive metastatic melanoma. Along with skin cancer drug, FDA approved Companion Diagnostic, a mutation diagnostic test. “Today’s approval of Zelboraf and the (companion) test is a great example of how companion diagnostics can be developed [...]

Prostate cancer: a new treatment option from Swedish Lund University researchers.

Researchers from Lund University have identified a method that may attack and destroy prostate cancer stem cells

Potential breakthrough in cancer research: a new treatment for leukemia had amazing results.   Zelboraf for metastatic melanoma approved by FDA.   Hereditary cancer: future methods of diagnosis and treatment   Swedish researchers from Lund University have identified a new treatment method for the advanced prostate cancer that may attack and destroy prostate cancer stem [...]

Potential breakthrough in cancer research: a new treatment for leukemia had amazing results.

"Microscopic image showing two T cells binding to beads, depicted in yellow, that cause the cells to divide. After the beads are removed, the T cells are infused into cancer patients." (Dr. Carl June / Pennsylvania Medicine)

Zelboraf for metastatic melanoma approved by FDA.   Prostate cancer: a new treatment option from Swedish Lund University researchers.   Telomere progressive shortening characterizes familial breast cancer   A new treatment for leukemia had amazing results, surprising even the researchers who designed it. The new treatment has eradicated the cancer cells present in the first [...]

Telomere progressive shortening characterizes familial breast cancer

Telomere chromosome

Prostate cancer: a new treatment option from Swedish Lund University researchers.   Zelboraf for metastatic melanoma approved by FDA.   Potential breakthrough in cancer research: a new treatment for leukemia had amazing results.   Hereditary cancer: future methods of diagnosis and treatment   Progressive telomere shortening characterizes familial breast cancer patients   Telomeres, the complex [...]

Photo Gallery

ADVERTISEMENT

Liked this post? You'll love our newsletter.

Enter your email to receive our weekly list of top news.

NEWSFEED

Recommended

ADVERTISEMENT

Front Page

ADVERTISEMENT